Zhejiang Shouxiangu Pharm Co (603896) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Zhejiang Shouxiangu Pharm Co (603896) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥20.94 Million ≈ $3.06 Million USD) by net assets (CN¥2.31 Billion ≈ $338.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603896 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Zhejiang Shouxiangu Pharm Co - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Zhejiang Shouxiangu Pharm Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Shouxiangu Pharm Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Shouxiangu Pharm Co ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhengzhou Coal Mining Machinery Group Company Limited F:ZGC	0.080x
China Datang Corporation Renewable Power Co. Limited F:DT7	0.046x
Shanghai HYP-ARCH Architectural Design Consultant Co.Ltd. SHE:301024	N/A
QingCloud Technologies Corp. SHG:688316	-0.111x
Shenzhen Hifuture Electric SHE:002168	-0.359x
Aic Mines Ltd AU:A1M	0.175x
Guangdong VTR Bio-Tech Co Ltd SHE:300381	0.021x
Jiangnan Yifan Motor Co.Ltd SHE:301023	N/A

Annual Cash Flow Conversion Efficiency for Zhejiang Shouxiangu Pharm Co (2012–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Shouxiangu Pharm Co from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Shouxiangu Pharm Co market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.26 Billion ≈ $330.77 Million	CN¥228.07 Million ≈ $33.37 Million	0.101x	+8.44%
2024-12-31	CN¥2.29 Billion ≈ $335.69 Million	CN¥213.44 Million ≈ $31.23 Million	0.093x	-35.88%
2023-12-31	CN¥2.17 Billion ≈ $317.73 Million	CN¥315.06 Million ≈ $46.10 Million	0.145x	-18.98%
2022-12-31	CN¥1.91 Billion ≈ $278.84 Million	CN¥341.28 Million ≈ $49.94 Million	0.179x	-2.21%
2021-12-31	CN¥1.62 Billion ≈ $237.06 Million	CN¥296.70 Million ≈ $43.42 Million	0.183x	-5.25%
2020-12-31	CN¥1.33 Billion ≈ $194.08 Million	CN¥256.36 Million ≈ $37.51 Million	0.193x	+9.00%
2019-12-31	CN¥1.17 Billion ≈ $171.57 Million	CN¥207.92 Million ≈ $30.42 Million	0.177x	+1.82%
2018-12-31	CN¥984.74 Million ≈ $144.10 Million	CN¥171.51 Million ≈ $25.10 Million	0.174x	+36.71%
2017-12-31	CN¥869.75 Million ≈ $127.27 Million	CN¥110.80 Million ≈ $16.21 Million	0.127x	-41.72%
2016-12-31	CN¥436.93 Million ≈ $63.94 Million	CN¥95.52 Million ≈ $13.98 Million	0.219x	-5.25%
2015-12-31	CN¥368.53 Million ≈ $53.93 Million	CN¥85.03 Million ≈ $12.44 Million	0.231x	-28.12%
2014-12-31	CN¥320.56 Million ≈ $46.91 Million	CN¥102.90 Million ≈ $15.06 Million	0.321x	+45.99%
2013-12-31	CN¥299.50 Million ≈ $43.83 Million	CN¥65.85 Million ≈ $9.64 Million	0.220x	-32.93%
2012-12-31	CN¥138.37 Million ≈ $20.25 Million	CN¥45.36 Million ≈ $6.64 Million	0.328x	--

About Zhejiang Shouxiangu Pharm Co

SHG:603896 China Biotechnology

Market Cap

$423.54 Million

CN¥2.89 Billion CNY

Market Cap Rank

#13251 Global

#3970 in China

Share Price

CN¥14.60

Change (1 day)

-7.12%

52-Week Range

CN¥14.60 - CN¥22.95

All Time High

CN¥56.07